Mumbai, India

Dwivedi Shriprakash Dhar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dwivedi Shriprakash Dhar. Retrieved from https://idiyas.com/inventor/dwivedi-shriprakash-dhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dwivedi Shriprakash Dhar: Innovator in Pharmaceutical Chemistry

Introduction

Dwivedi Shriprakash Dhar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.

Latest Patents

One of his key patents is titled "Salts of nilotinib and polymorphs thereof." This invention provides novel salts of nilotinib and polymorphs, including acid addition salts of nilotinib with various acids such as benzenesulfonic acid and butanedisulfonic acid. The patent also covers hydrates and anhydrates of these compounds. He holds 1 patent in this area.

Career Highlights

Dwivedi is currently associated with Sun Pharmaceutical Industries Limited, a leading pharmaceutical company. His work focuses on innovative solutions that enhance the efficacy of pharmaceutical products.

Collaborations

He has collaborated with notable colleagues, including Rajamannar Thennati and Srinivasu Kilaru, to advance research and development in his field.

Conclusion

Dwivedi Shriprakash Dhar's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work continues to influence the development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…